Skip to main content
Erschienen in: Metabolic Brain Disease 5/2017

15.05.2017 | Original Article

Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours

verfasst von: O. J. Onaolapo, T. B. Paul, A. Y. Onaolapo

Erschienen in: Metabolic Brain Disease | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Effects of sertraline, haloperidol or olanzapine administration on ketamine-induced behaviours in mice were examined. The aim was to ascertain the degree of reversal of such behaviours by sertraline, and compare its effectiveness to haloperidol and olanzapine. Ten-week old mice (N = 120) were equally divided into main groups; 1 (open-field, radial-arm maze and elevated plus maze {EPM} tests), and 2 (social interaction test). Mice in each main group were assigned into six groups of ten (n = 10) each. Group 1 received intraperitoneal (i.p) injection of vehicle, while groups 2–6 received i.p ketamine at 15 mg/kg daily for 10 days. From day 11 to 24, mice in group 1 (vehicle) were given distilled water (i.p at 2 ml/kg and oral at 10 ml/kg), group 2 (ketamine control) received daily i.p ketamine and oral distilled water; while animals in groups 3–6 received daily i.p. ketamine and oral haloperidol (4 mg/kg), olanzapine (2 mg/kg), or one of two doses of sertraline (SERT) (2.5 or 5 mg/kg), respectively. Treatments were administered daily, and behaviours assessed on days 11 and 24. Results showed that repeated ketamine administration caused hyperlocomotion, increased self-grooming, memory loss and social withdrawal. Administration of sertraline (both doses), haloperidol, and olanzapine reversed ketamine-induced behavioural changes. However, in the EPM, sertraline and olanzapine were anxiolytic, while haloperidol was anxiogenic. Sertraline’s effect on behaviours tested was comparable to olanzapine and better than haloperidol. In conclusion, this study shows that sertraline’s ability to counteract ketamine-induced behavioural changes in mice is comparable to known antipsychotics.
Literatur
Zurück zum Zitat Abekawa T, Koki I, Nakagawa S, Nakato Y, Koyama T (2008) Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia- like behavioral abnormalities and accompanied apoptosis in the medial pre- frontal cortex. Schizophr Res 101:84–94CrossRefPubMed Abekawa T, Koki I, Nakagawa S, Nakato Y, Koyama T (2008) Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia- like behavioral abnormalities and accompanied apoptosis in the medial pre- frontal cortex. Schizophr Res 101:84–94CrossRefPubMed
Zurück zum Zitat Ajayi AA, Ukponmwan OE (1994) Possible evidence of angiotensin II and endogenous opioid modulation of novelty-induced rearing in the rat. Afr J Med Med Sci 23:287–290PubMed Ajayi AA, Ukponmwan OE (1994) Possible evidence of angiotensin II and endogenous opioid modulation of novelty-induced rearing in the rat. Afr J Med Med Sci 23:287–290PubMed
Zurück zum Zitat Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4:399–408CrossRefPubMed Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4:399–408CrossRefPubMed
Zurück zum Zitat Bailey KR, Crawley JN (2009) Chapter 5, anxiety-related behaviors in mice. In: Buccafusco JJ (ed) Methods of behavior analysis in neuroscience, 2nd edn. CRC Press/Taylor & Francis, Boca Raton Bailey KR, Crawley JN (2009) Chapter 5, anxiety-related behaviors in mice. In: Buccafusco JJ (ed) Methods of behavior analysis in neuroscience, 2nd edn. CRC Press/Taylor & Francis, Boca Raton
Zurück zum Zitat Becker A, Grecksch G (2004) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Prog Neuropsychopharmacol Biol Psychiatry 28:1267–1277CrossRefPubMed Becker A, Grecksch G (2004) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Prog Neuropsychopharmacol Biol Psychiatry 28:1267–1277CrossRefPubMed
Zurück zum Zitat Bilge U, Erol K (2012) Effects of sertraline on experimental mouse models of psychosis. Neurosciences (Riyadh) 17:32–38 Bilge U, Erol K (2012) Effects of sertraline on experimental mouse models of psychosis. Neurosciences (Riyadh) 17:32–38
Zurück zum Zitat Briones-Aranda A, Suárez-Santiago JE, Picazo O, Castellanos-Pérez M (2016) Effect of ketamine administration, alone and in combination with E-6837, on climbing behavior. Behav Pharmacol 27:485–488CrossRefPubMed Briones-Aranda A, Suárez-Santiago JE, Picazo O, Castellanos-Pérez M (2016) Effect of ketamine administration, alone and in combination with E-6837, on climbing behavior. Behav Pharmacol 27:485–488CrossRefPubMed
Zurück zum Zitat Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein H, Steiner J, Bogerts B, Braun K, Jankowski Z, Kumaratilake J, Henneberg M, Gos T (2014) The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry 5:47PubMedPubMedCentral Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein H, Steiner J, Bogerts B, Braun K, Jankowski Z, Kumaratilake J, Henneberg M, Gos T (2014) The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry 5:47PubMedPubMedCentral
Zurück zum Zitat Bubenıkova-Valesova V, Horacek J, Vrajova M, Hoschl C (2008) Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 32:1014–1023CrossRefPubMed Bubenıkova-Valesova V, Horacek J, Vrajova M, Hoschl C (2008) Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 32:1014–1023CrossRefPubMed
Zurück zum Zitat Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29:1193–1205CrossRefPubMed Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29:1193–1205CrossRefPubMed
Zurück zum Zitat Cassaday HJ, Thur KE (2015) Intraperitoneal sertraline and fluvoxamine increase contextual fear conditioning but are without effect on overshadowing between cues. Pharmacol Biochem. Behav. 129:111–115 Cassaday HJ, Thur KE (2015) Intraperitoneal sertraline and fluvoxamine increase contextual fear conditioning but are without effect on overshadowing between cues. Pharmacol Biochem. Behav. 129:111–115
Zurück zum Zitat Chatterjee M, Ganguly S, Srivastava M, Palit G (2011) Effect of ‘chronic’ versus ‘acute’ ketamine administration and its ‘withdrawal’ effect on behavioural alterations in mice: implications for experimental psychosis. Behav Brain Res 216:247–254CrossRefPubMed Chatterjee M, Ganguly S, Srivastava M, Palit G (2011) Effect of ‘chronic’ versus ‘acute’ ketamine administration and its ‘withdrawal’ effect on behavioural alterations in mice: implications for experimental psychosis. Behav Brain Res 216:247–254CrossRefPubMed
Zurück zum Zitat Chatterjee M, Verma R, Ganguly S, Palit G (2012) Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice. Neuropharmacology 63:1161–1171CrossRefPubMed Chatterjee M, Verma R, Ganguly S, Palit G (2012) Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice. Neuropharmacology 63:1161–1171CrossRefPubMed
Zurück zum Zitat Chen W, Zhang Q, Su W, Zhang H, Yang Y, Qiao J, Sui N, Li M (2014) Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats. Pharmacol Biochem Behav 117:25–33CrossRefPubMed Chen W, Zhang Q, Su W, Zhang H, Yang Y, Qiao J, Sui N, Li M (2014) Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats. Pharmacol Biochem Behav 117:25–33CrossRefPubMed
Zurück zum Zitat Chertkow Y, Weinreb O, Youdim MB, Silver H (2007) Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment. J Neural Transm 114:1443–1454CrossRefPubMed Chertkow Y, Weinreb O, Youdim MB, Silver H (2007) Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment. J Neural Transm 114:1443–1454CrossRefPubMed
Zurück zum Zitat Corbett R, Fielding S, Cornfeldt M, Dunn RW (1991) GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures. Psychopharmacol (Berl) 104(3):312–316CrossRef Corbett R, Fielding S, Cornfeldt M, Dunn RW (1991) GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures. Psychopharmacol (Berl) 104(3):312–316CrossRef
Zurück zum Zitat D’Agostino G, Cristiano CDJ, Citraro R et al (2015) Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice. Mol Metab 24:528–536CrossRef D’Agostino G, Cristiano CDJ, Citraro R et al (2015) Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice. Mol Metab 24:528–536CrossRef
Zurück zum Zitat Duan TT, Tan JW, Yuan Q, Cao J, Zhou Q-x, Xu L (2013) Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors. Psychopharmacology 228:451–461CrossRefPubMed Duan TT, Tan JW, Yuan Q, Cao J, Zhou Q-x, Xu L (2013) Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors. Psychopharmacology 228:451–461CrossRefPubMed
Zurück zum Zitat El Mansari M, Blier P (2006) Mechanisms of action of current and potential pharmacotherapies. Prog Neuro-Psychopharmacol Biol Psychiatry 30:362–373CrossRef El Mansari M, Blier P (2006) Mechanisms of action of current and potential pharmacotherapies. Prog Neuro-Psychopharmacol Biol Psychiatry 30:362–373CrossRef
Zurück zum Zitat Engin E, Treit D, Dickson CT (2009) Anxiolytic-and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience 161:359–369CrossRefPubMed Engin E, Treit D, Dickson CT (2009) Anxiolytic-and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience 161:359–369CrossRefPubMed
Zurück zum Zitat Farahmandfar M, Akbarabadi A, Bakhtazad A, Zarrindast MR (2017) Recovery from ketamine-induced amnesia by blockade of GABA-A receptor in the medial prefrontal cortex of mice. Neuroscience 344:48–55CrossRefPubMed Farahmandfar M, Akbarabadi A, Bakhtazad A, Zarrindast MR (2017) Recovery from ketamine-induced amnesia by blockade of GABA-A receptor in the medial prefrontal cortex of mice. Neuroscience 344:48–55CrossRefPubMed
Zurück zum Zitat File SE, Wardill AG (1975) The reliability of the hole-board apparatus. Psychopharmacologia 44:47–51CrossRefPubMed File SE, Wardill AG (1975) The reliability of the hole-board apparatus. Psychopharmacologia 44:47–51CrossRefPubMed
Zurück zum Zitat Flaisher-Grinberg S, Klavir O, Joel D (2008) The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive–compulsive disorder. Intern J Neuropsychopharmacol 11:811–825CrossRef Flaisher-Grinberg S, Klavir O, Joel D (2008) The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive–compulsive disorder. Intern J Neuropsychopharmacol 11:811–825CrossRef
Zurück zum Zitat Fraga DB, Réus GZ, Abelaira HM, De Luca RD, Canever L, Pfaffenseller B, Colpo GD, Kapczinski F, Quevedo J, Zugno AI(2013) Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration. Rev Bras Psiquiatr 35. doi:10.1590/1516-4446-2012-0858 Fraga DB, Réus GZ, Abelaira HM, De Luca RD, Canever L, Pfaffenseller B, Colpo GD, Kapczinski F, Quevedo J, Zugno AI(2013) Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration. Rev Bras Psiquiatr 35. doi:10.​1590/​1516-4446-2012-0858
Zurück zum Zitat Gama CS, Canever L, Panizzutti B, Gubert C, Stertz L, Massuda R, Zugno AI (2012) Effects of omega-3 dietary supplement in prevention of positive, negative, and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophr Res 141:162–167CrossRefPubMed Gama CS, Canever L, Panizzutti B, Gubert C, Stertz L, Massuda R, Zugno AI (2012) Effects of omega-3 dietary supplement in prevention of positive, negative, and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophr Res 141:162–167CrossRefPubMed
Zurück zum Zitat Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79–84CrossRefPubMed Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79–84CrossRefPubMed
Zurück zum Zitat Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF (1996) Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54:129–141CrossRefPubMed Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF (1996) Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54:129–141CrossRefPubMed
Zurück zum Zitat Gráf M (2006) 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder. Neuropsychopharmacol Hung 8:23–28PubMed Gráf M (2006) 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder. Neuropsychopharmacol Hung 8:23–28PubMed
Zurück zum Zitat Graves L, Dalvi A, Lucki I, Blendy JA, Abel T (2002) Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background. Hippocampus 12:18–26CrossRefPubMed Graves L, Dalvi A, Lucki I, Blendy JA, Abel T (2002) Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background. Hippocampus 12:18–26CrossRefPubMed
Zurück zum Zitat Greenberg GD, Laman-Maharg A, Campi KL, Voigt H, Orr VN, Schaal L, Traino BC (2013) Sex differences in stress-induced social withdrawal: Role of brain derived neurotrophic factor in the bed nucleus of the stria terminalis. Front Behav Neurosci 7:223PubMed Greenberg GD, Laman-Maharg A, Campi KL, Voigt H, Orr VN, Schaal L, Traino BC (2013) Sex differences in stress-induced social withdrawal: Role of brain derived neurotrophic factor in the bed nucleus of the stria terminalis. Front Behav Neurosci 7:223PubMed
Zurück zum Zitat Griebel G, Moreau JL, Jenck F, Misslin R, Martin JR (1994) Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 113(3–4):463–470CrossRefPubMed Griebel G, Moreau JL, Jenck F, Misslin R, Martin JR (1994) Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 113(3–4):463–470CrossRefPubMed
Zurück zum Zitat Hirano K, Kimura R, Sugimoto Y, Yamada J, Uchida S, Kato Y, Hashimoto H, Yamada S (2005) Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. Br J Pharmacol 144:695–702CrossRefPubMedPubMedCentral Hirano K, Kimura R, Sugimoto Y, Yamada J, Uchida S, Kato Y, Hashimoto H, Yamada S (2005) Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. Br J Pharmacol 144:695–702CrossRefPubMedPubMedCentral
Zurück zum Zitat Hong W, Kim D-w, Anderson DJ (2014) Antagonistic control of social versus repetitive self-grooming behaviors by separable amygdala neuronal subsets. Cell 158:1348–1361CrossRefPubMedPubMedCentral Hong W, Kim D-w, Anderson DJ (2014) Antagonistic control of social versus repetitive self-grooming behaviors by separable amygdala neuronal subsets. Cell 158:1348–1361CrossRefPubMedPubMedCentral
Zurück zum Zitat Hudon C, Doré FY, Goulet S (2002) Spatial memory and choice behavior in the radial arm maze after fornix transection. Prog Neuro-Psychopharmacol Biol Psychiatry 26:1113–1123CrossRef Hudon C, Doré FY, Goulet S (2002) Spatial memory and choice behavior in the radial arm maze after fornix transection. Prog Neuro-Psychopharmacol Biol Psychiatry 26:1113–1123CrossRef
Zurück zum Zitat Iasevoli F, Tomasetti C, Buonaguro EF, de Bartolomeis A (2014) The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment. Curr Neuropharmacol 12:219–238CrossRefPubMedPubMedCentral Iasevoli F, Tomasetti C, Buonaguro EF, de Bartolomeis A (2014) The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment. Curr Neuropharmacol 12:219–238CrossRefPubMedPubMedCentral
Zurück zum Zitat Imre G, Fokkema DS, Den Boer JA, Ter Horst GJ (2006) Dose–response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Res Bull 69:338–345CrossRefPubMed Imre G, Fokkema DS, Den Boer JA, Ter Horst GJ (2006) Dose–response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Res Bull 69:338–345CrossRefPubMed
Zurück zum Zitat Javitt DC (2007) Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int RevNeurobiol 78:69–108 Javitt DC (2007) Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int RevNeurobiol 78:69–108
Zurück zum Zitat Kalueff AA, Stewart AM, Song C, Berridge KC, Graybiel AM, Fentress JC (2016) Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat Rev Neurosci 17:45–59CrossRefPubMed Kalueff AA, Stewart AM, Song C, Berridge KC, Graybiel AM, Fentress JC (2016) Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat Rev Neurosci 17:45–59CrossRefPubMed
Zurück zum Zitat Kamiyama H, Matsumoto M, Otani S, Kimura SI, Shimamura KI, Ishikawa S, Yanagawa Y, Togashi H (2011) Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway. Neuroscience 177:159–169CrossRefPubMed Kamiyama H, Matsumoto M, Otani S, Kimura SI, Shimamura KI, Ishikawa S, Yanagawa Y, Togashi H (2011) Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway. Neuroscience 177:159–169CrossRefPubMed
Zurück zum Zitat Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kakuta A, Izumi T, Koyama T (2010) Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. Eur J Pharmacol 647:90–96CrossRefPubMed Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kakuta A, Izumi T, Koyama T (2010) Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. Eur J Pharmacol 647:90–96CrossRefPubMed
Zurück zum Zitat Kreilgaard M, Smith D, Brennum LT, Sánchez C (2008) Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice. Br J Pharmacol 155:276–284CrossRefPubMedPubMedCentral Kreilgaard M, Smith D, Brennum LT, Sánchez C (2008) Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice. Br J Pharmacol 155:276–284CrossRefPubMedPubMedCentral
Zurück zum Zitat Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199–214CrossRefPubMed Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199–214CrossRefPubMed
Zurück zum Zitat Lee PR, Brady DL, Shapiro RA, Dorsa DM, Koenig JI (2005) Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 30:1883–1894CrossRefPubMed Lee PR, Brady DL, Shapiro RA, Dorsa DM, Koenig JI (2005) Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 30:1883–1894CrossRefPubMed
Zurück zum Zitat Li XM, Perry KW, Wong DT, Bymaster FP (1998) Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136:153–161CrossRefPubMed Li XM, Perry KW, Wong DT, Bymaster FP (1998) Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136:153–161CrossRefPubMed
Zurück zum Zitat Mao M-y, Zhang M-d (2015) Augmentation with antidepressants in schizophrenia treatment: benefit or risk. Neuropsychiatr Dis Treat 11:701–713PubMedPubMedCentral Mao M-y, Zhang M-d (2015) Augmentation with antidepressants in schizophrenia treatment: benefit or risk. Neuropsychiatr Dis Treat 11:701–713PubMedPubMedCentral
Zurück zum Zitat Mathiasen LS, Mirza NR, Rodgers RJ (2008) Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice. Pharmacol Biochem Behav 90:19–36CrossRefPubMed Mathiasen LS, Mirza NR, Rodgers RJ (2008) Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice. Pharmacol Biochem Behav 90:19–36CrossRefPubMed
Zurück zum Zitat McOmish CE, Lira A, Hanks JB, Gingrich JA (2012) Clozapine-induced locomotor suppression is mediated by 5-ht2a receptors in the forebrain. Neuropsychopharmacology 37:2747–2755CrossRefPubMedPubMedCentral McOmish CE, Lira A, Hanks JB, Gingrich JA (2012) Clozapine-induced locomotor suppression is mediated by 5-ht2a receptors in the forebrain. Neuropsychopharmacology 37:2747–2755CrossRefPubMedPubMedCentral
Zurück zum Zitat Mombereau C, Gur TM, Onksen J, Blendy JA (2010) Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. Int J Neuropsychopharmacol 13:321–334CrossRefPubMed Mombereau C, Gur TM, Onksen J, Blendy JA (2010) Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. Int J Neuropsychopharmacol 13:321–334CrossRefPubMed
Zurück zum Zitat Mutlu O, Ulak G, Celikyurt IK, Akar FY, Erden F, Tanyeri P (2011) Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice. Pharmacol Biochem Behav 99:557–565CrossRefPubMed Mutlu O, Ulak G, Celikyurt IK, Akar FY, Erden F, Tanyeri P (2011) Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice. Pharmacol Biochem Behav 99:557–565CrossRefPubMed
Zurück zum Zitat Onaolapo OJ, Onaolapo AY, Akinola OR, Anisulowo TO (2014) Dexamethasone regimens alter spatial memory and anxiety levels in mice. J Behav Brain Sci 4:159–167CrossRef Onaolapo OJ, Onaolapo AY, Akinola OR, Anisulowo TO (2014) Dexamethasone regimens alter spatial memory and anxiety levels in mice. J Behav Brain Sci 4:159–167CrossRef
Zurück zum Zitat Onaolapo OJ, Ayanwale T, Agoi O, Adetimehin C, Onaolapo AY (2016a) Zinc tempers haloperidol-induced behavioural changes in healthy mice. International J Neurosci Behav Sci 4:21–31 Onaolapo OJ, Ayanwale T, Agoi O, Adetimehin C, Onaolapo AY (2016a) Zinc tempers haloperidol-induced behavioural changes in healthy mice. International J Neurosci Behav Sci 4:21–31
Zurück zum Zitat Onaolapo AY, Onaolapo OJ, Nwoha PU (2016b) Alterations in behaviour, cerebral cortical morphology and cerebral oxidative stress markers following aspartame ingestion. J Chem Neuroanat 78:42–56CrossRefPubMed Onaolapo AY, Onaolapo OJ, Nwoha PU (2016b) Alterations in behaviour, cerebral cortical morphology and cerebral oxidative stress markers following aspartame ingestion. J Chem Neuroanat 78:42–56CrossRefPubMed
Zurück zum Zitat Onaolapo OJ, Onaolapo AY, Akanmu MA, Olayiwola G (2016c) Changes in spontaneous working-memory, memory-recall and approach-avoidance following “low dose” monosodium glutamate in mice. AIMS Neurosci 3:317–337CrossRef Onaolapo OJ, Onaolapo AY, Akanmu MA, Olayiwola G (2016c) Changes in spontaneous working-memory, memory-recall and approach-avoidance following “low dose” monosodium glutamate in mice. AIMS Neurosci 3:317–337CrossRef
Zurück zum Zitat Onaolapo AY, Adebayo AN, Onaolapo OJ (2017a) Exogenous daytime melatonin modulates response of adolescent mice in a repeated unpredictable stress paradigm Naunyn-Schmiedeberg’s arch. Pharmacology 390:149–161 Onaolapo AY, Adebayo AN, Onaolapo OJ (2017a) Exogenous daytime melatonin modulates response of adolescent mice in a repeated unpredictable stress paradigm Naunyn-Schmiedeberg’s arch. Pharmacology 390:149–161
Zurück zum Zitat Onaolapo AY, Onaolapo OJ, Nwoha PU (2017b) Aspartame and the hippocampus: revealing a bi-directional, dose/time-dependent behavioural and morphological shift in mice. Neurobiol Learn Mem 139:76–88CrossRefPubMed Onaolapo AY, Onaolapo OJ, Nwoha PU (2017b) Aspartame and the hippocampus: revealing a bi-directional, dose/time-dependent behavioural and morphological shift in mice. Neurobiol Learn Mem 139:76–88CrossRefPubMed
Zurück zum Zitat Parise EM, Alcantara LF, Warren BL, Wright KN, Hadad R, Sial OK, Kroeck KG, Iñiguez SD, Bolaños-Guzmán CA (2013) Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats. Biol Psychiatry 74:750–759CrossRefPubMedPubMedCentral Parise EM, Alcantara LF, Warren BL, Wright KN, Hadad R, Sial OK, Kroeck KG, Iñiguez SD, Bolaños-Guzmán CA (2013) Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats. Biol Psychiatry 74:750–759CrossRefPubMedPubMedCentral
Zurück zum Zitat Patel KR, Cherian J, Gohil L, Atkinson D (2014) Schizophrenia: overview and treatment options. Pharn Ther 39:638–645 Patel KR, Cherian J, Gohil L, Atkinson D (2014) Schizophrenia: overview and treatment options. Pharn Ther 39:638–645
Zurück zum Zitat Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167CrossRefPubMed Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167CrossRefPubMed
Zurück zum Zitat Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA, Duan W (2008) The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington’s disease mouse model. Exp Neurol 210:154–163CrossRefPubMed Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA, Duan W (2008) The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington’s disease mouse model. Exp Neurol 210:154–163CrossRefPubMed
Zurück zum Zitat Pereira-Figueiredo I, Sancho C, Carro J, Castellano O, López DE (2014) The effects of sertraline administration from adolescence to adulthood on physiological and emotional development in prenatally stressed rats of both sexes. Front Behav Neurosci 8:260CrossRefPubMedPubMedCentral Pereira-Figueiredo I, Sancho C, Carro J, Castellano O, López DE (2014) The effects of sertraline administration from adolescence to adulthood on physiological and emotional development in prenatally stressed rats of both sexes. Front Behav Neurosci 8:260CrossRefPubMedPubMedCentral
Zurück zum Zitat Qiao H, Noda Y, Kamei H, Nagai T, Furukawa H, Miura H et al (2001) Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment. Neuroreport 12:11–15CrossRefPubMed Qiao H, Noda Y, Kamei H, Nagai T, Furukawa H, Miura H et al (2001) Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment. Neuroreport 12:11–15CrossRefPubMed
Zurück zum Zitat Roberts BM, Holden DE, Shaffer CL et al (2010) Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction. Behav Brain Res 212:41–48CrossRefPubMed Roberts BM, Holden DE, Shaffer CL et al (2010) Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction. Behav Brain Res 212:41–48CrossRefPubMed
Zurück zum Zitat Santuzzi CH, Futuro Neto HA, Pires JGP, Gonçalves WLS, Tiradentes RV, Gouvea, SA, Abreu GR (2012) Sertraline inhibits formalin-induced nociception and cardiovascular responses. Braz J Med Biol Res. 45:43–48. doi:10.1590/S0100-879X2011007500154 Santuzzi CH, Futuro Neto HA, Pires JGP, Gonçalves WLS, Tiradentes RV, Gouvea, SA, Abreu GR (2012) Sertraline inhibits formalin-induced nociception and cardiovascular responses. Braz J Med Biol Res. 45:43–48. doi:10.​1590/​S0100-879X201100750015​4
Zurück zum Zitat Scarr E, Dean B (2009) Role of the cholinergic system in the pathology and treatment of schizophrenia. Expert Rev Neurother 9:73–86CrossRefPubMed Scarr E, Dean B (2009) Role of the cholinergic system in the pathology and treatment of schizophrenia. Expert Rev Neurother 9:73–86CrossRefPubMed
Zurück zum Zitat Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B et al (2008) Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 33:1323–1133CrossRefPubMed Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B et al (2008) Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 33:1323–1133CrossRefPubMed
Zurück zum Zitat Schumacher A, Sivanandan B, Tolledo EC, Woldegabrie J, Ito R (2016) Different dosing regimens of repeated ketamine administration have opposite effects on novelty processing in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 69:1–10CrossRef Schumacher A, Sivanandan B, Tolledo EC, Woldegabrie J, Ito R (2016) Different dosing regimens of repeated ketamine administration have opposite effects on novelty processing in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 69:1–10CrossRef
Zurück zum Zitat Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583–594CrossRefPubMed Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583–594CrossRefPubMed
Zurück zum Zitat Silva RC, Brandao ML (2000) Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav 65:209–216CrossRefPubMed Silva RC, Brandao ML (2000) Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav 65:209–216CrossRefPubMed
Zurück zum Zitat Stanford JA, Currier TD, Gerhardt GA (2002) Acute locomotor effects of fluoxetine, sertraline and nomifensine in young versus aged Fischer 344 rats. Pharmacol Biochem Behav 71:325–332CrossRefPubMed Stanford JA, Currier TD, Gerhardt GA (2002) Acute locomotor effects of fluoxetine, sertraline and nomifensine in young versus aged Fischer 344 rats. Pharmacol Biochem Behav 71:325–332CrossRefPubMed
Zurück zum Zitat Taler M, Miron O, Gil-Ad I, Weizman A (2013) Neuroprotective and procognitive effects of sertraline: in vitro and in vivo studies. Neurosci Lett 550:93–97CrossRefPubMed Taler M, Miron O, Gil-Ad I, Weizman A (2013) Neuroprotective and procognitive effects of sertraline: in vitro and in vivo studies. Neurosci Lett 550:93–97CrossRefPubMed
Zurück zum Zitat Thomas DN, Nutt DJ, Holman RB (1998) Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex. J Psychopharmacol 12:366–370CrossRefPubMed Thomas DN, Nutt DJ, Holman RB (1998) Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex. J Psychopharmacol 12:366–370CrossRefPubMed
Zurück zum Zitat Thomsen MS, Christensen DZ, Hansen HH, Redrobe JP, Mikkelsen JD (2009) Alpha(7) nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 56:1001–1009CrossRefPubMed Thomsen MS, Christensen DZ, Hansen HH, Redrobe JP, Mikkelsen JD (2009) Alpha(7) nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 56:1001–1009CrossRefPubMed
Zurück zum Zitat Wilson CA, Koenig JI (2014) Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia. Eur Neuropsychopharmacol 24:759–773CrossRefPubMed Wilson CA, Koenig JI (2014) Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia. Eur Neuropsychopharmacol 24:759–773CrossRefPubMed
Zurück zum Zitat Xu H, Yang HJ, Rose GM (2012) Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D(1) and D(2) receptors in the caudate putamen of C57BL/6 mouse. Life Sci 91:322–328CrossRefPubMed Xu H, Yang HJ, Rose GM (2012) Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D(1) and D(2) receptors in the caudate putamen of C57BL/6 mouse. Life Sci 91:322–328CrossRefPubMed
Zurück zum Zitat Yildirim E, Erol K, Ulupinar E (2012) Effects of sertraline on behavioral alterations caused by environmental enrichment and social isolation. Pharmacol Biochem Behav 101:278–287CrossRefPubMed Yildirim E, Erol K, Ulupinar E (2012) Effects of sertraline on behavioral alterations caused by environmental enrichment and social isolation. Pharmacol Biochem Behav 101:278–287CrossRefPubMed
Metadaten
Titel
Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours
verfasst von
O. J. Onaolapo
T. B. Paul
A. Y. Onaolapo
Publikationsdatum
15.05.2017
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 5/2017
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-0031-3

Weitere Artikel der Ausgabe 5/2017

Metabolic Brain Disease 5/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.